Abstract
In a recent communication Reicher1reports three cases of pernicious anemia and one of secondary anemia referable to nephritis in which cholesterin was used for therapeutic purposes, the idea in mind being to counteract any hemolysins that might be active, in a manner analogous to the action of cholesterin on cobralecithid. Similar considerations led me to the same attempt over a year ago. But as I have had only six cases of pernicious anemia at my disposal during that time, I hardly thought my data sufficient to warrant their publication. Reicher's paper, however, makes it desirable to place on record the little that has been done. All six were typical cases of cryptogenetic pernicious anemia, one of them being of the so-called aplastic type. Three patients were in an advanced state of the disease when coming under observation and only lived for a few weeks; in these no effect
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
